GREGORY L WEAVER Insider Trading $ATRX Adhera Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY L WEAVER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY L WEAVER. GREGORY L WEAVER is Chief Financial Officer in Marina Biotech, Inc. ($MRNA) and Director in Celsion CORP ($CLSN) and in Eloxx Pharmaceuticals, Inc. ($ELOX) and Chief Financial Officer in Eloxx Pharmaceuticals, Inc. ($SVON) and Director in ATOSSA GENETICS INC ($ATOS) and Director in Egalet Corp ($EGLT).
GREGORY L WEAVER in Adhera Therapeutics, Inc.
Trading Symbol: ATRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY L WEAVER: Chief Financial Officer
Holdings: 16,000 shares
Current Value: $3,200
Latest Transaction: May 27 2005
$ATRX Market Capitalization: $626850.00
$ATRX Previous Close: $0.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY L WEAVER in Adhera Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, ATOS, CLSN, ELOX, EGLT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2005 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 11.54 | 7,500 | 86,550 | 165,000 | |
May 27 2005 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 16,000 | 8.5 K to 16 K (+88.24 %) |
Jun 14 2004 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 11.24 | 7,500 | 84,300 | 90,834 | |
Jun 14 2004 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 8,500 | 1,000 to 8.5 K (+750.00 %) |
Page: 1